Avapritinib: a new tyrosine kinase inhibitor for treatment of advanced gastrointestinal stromal tumors. The literature review and clinical case

por Daria A. Filonenko, Bela M. Medvedeva, Andrey A. Meshcheryakov
Publicado 2021

SDH-deficient gastrointestinal stromal tumors: paradoxical effect of imatinib

por Daria A. Filonenko, Andrey A. Meshcheryakov, Petr P. Arkhiri, Maxim P. Nikulin, Evgeniia S. Kolobanova
Publicado 2020